Delayed recognition of levetiracetam-induced pancytopenia

5Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Blood dyscrasias associated with levetiracetam use can be difficult to identify, especially when other potential differential diagnoses are concurrently present. Here we present a 57-year-old man with metastatic adenocarcinoma of unknown primary origin on levetiracetam who initially presented with an in-stent thrombosis of the right external iliac vein and then developed worsening thrombocytopenia followed by pancytopenia. Levetiracetam was not identified as the culprit until other causes like platelet consumption, heparin-induced thrombocytopenia, idiopathic immune thrombocytopenic purpura, and bone marrow involvement by metastatic disease were ruled out.

Cite

CITATION STYLE

APA

Din, M. A. U., Hussain, S. A., & Bodrog, A. (2021). Delayed recognition of levetiracetam-induced pancytopenia. European Journal of Case Reports in Internal Medicine, 8(3). https://doi.org/10.12890/2021_002449

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free